We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$484B
AUM Growth
-$4.92B
Cap. Flow
+$23.6B
Cap. Flow %
4.87%
Top 10 Hldgs %
31.76%
Holding
15,382
New
1,669
Increased
5,510
Reduced
5,992
Closed
1,922

Sector Composition

Rank Sector Weight
1 Technology 2.72%
2 Healthcare 2.38%
3 Financials 2.3%
4 Consumer Discretionary 1.76%
5 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYNE
12301
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$86K ﹤0.01%
41,665
-89,531
-68% -$213K
BNED icon
12302
Barnes & Noble Education
BNED
$444M
$85K ﹤0.01%
+237
New +$127K
STEX
12303
PUT
Streamex Corp
STEX
$82.5M
$85K ﹤0.01%
7,390
-1,780
-19% -$28.4K
CUE icon
12304
PUT
Cue Biopharma
CUE
$110M
$85K ﹤0.01%
583
+16
+3% +$3.39K
GYRE icon
12305
CALL
Gyre Therapeutics
GYRE
$749M
$85K ﹤0.01%
17,173
-20,547
-54% -$102K
ORKA
12306
CALL
Oruka Therapeutics
ORKA
$6.34B
$85K ﹤0.01%
3,067
+667
+28% +$16.5K
VCSA
12307
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$85K ﹤0.01%
+517
New +$75.5K
WEJO
12308
CALL
DELISTED
Wejo Group Limited Common Shares
WEJO
$85K ﹤0.01%
+21,000
New +$91K
DTEA
12309
CALL
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$85K ﹤0.01%
30,200
+1,600
+6% +$4.92K
PTOCW
12310
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
$85K ﹤0.01%
380,855
ATHX
12311
PUT
DELISTED
Athersys, Inc. Common Stock
ATHX
$85K ﹤0.01%
5,628
-9,380
-63% -$196K
ALLT icon
12312
CALL
Allot
ALLT
$369M
$84K ﹤0.01%
+10,400
New +$94.8K
CERS icon
12313
PUT
Cerus
CERS
$508M
$84K ﹤0.01%
15,300
-36,900
-71% -$204K
ELP
12314
CALL
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
$84K ﹤0.01%
+13,500
New +$70.7K
PLUR icon
12315
CALL
Pluri
PLUR
$19.9M
$84K ﹤0.01%
5,063
-13,650
-73% -$197K
RCAT icon
12316
CALL
Red Cat Holdings
RCAT
$1.52B
$84K ﹤0.01%
41,500
-45,900
-53% -$88.3K
LNAI
12317
CALL
Lunai Bioworks
LNAI
$10.7M
$84K ﹤0.01%
+128
New +$68.2K
SUPV
12318
Grupo Supervielle
SUPV
$742M
$84K ﹤0.01%
+41,627
New +$79.4K
PHLT
12319
CALL
DELISTED
Performant Healthcare Inc
PHLT
$84K ﹤0.01%
26,900
+15,000
+126% +$35.3K
SOAR.WS
12320
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$84K ﹤0.01%
+300,000
New +$95.2K
HARP
12321
CALL
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$84K ﹤0.01%
1,680
-620
-27% -$32.1K
SEAC
12322
DELISTED
Seachange International Inc
SEAC
$84K ﹤0.01%
3,728
+1,758
+89% +$44.5K
ELMS
12323
CALL
DELISTED
Electric Last Mile Solutions, Inc. Class A Common stock
ELMS
$84K ﹤0.01%
58,600
+9,000
+18% +$29.3K
ACTG icon
12324
CALL
Acacia Research
ACTG
$465M
$83K ﹤0.01%
18,400
-13,400
-42% -$56.3K
FLUX icon
12325
PUT
Flux Power
FLUX
$11.2M
$83K ﹤0.01%
31,200
-5,100
-14% -$15.5K

Similar funds

Citadel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Citadel Advisors held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Citadel Advisors deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.

  • Citadel Advisors's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
  • Citadel Advisors's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
  • Citadel Advisors fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
  • Citadel Advisors's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
  • Citadel Advisors opened 1,669 new positions and closed 1,922 in Q1 2022.
  • Citadel Advisors's portfolio value fell 1% quarter-over-quarter to $484B.

Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.